Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin - the Association With Metabolic Control of Diabetes and Markers of Early Vascular Changes

NCT07919236 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07919236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin - the Association With Metabolic Control of Diabetes and Markers of Early Vascular Changes
Lead sponsor
Medical University of Bialystok
Phase
Not applicable
Overall status
Recruiting
Start date
November 30, 2026
Completion date
May 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes

Arms

As registered; 2 arms.

  • Continuous glucose monitoring ExperimentalContinuous glucose monitoring

    Dexcom One+ continuous glucose monitoring system

  • Self-monitoring of blood glucose OtherSelf-monitoring of blood glucose

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in time in range Week 12

    Observed change in time in range (70-180 mg/dl) from baseline to week 12 in the group using CGM system compared to the group using SMBG.

Lead sponsor's other trials

Medical University of Bialystok, most recent start first.

Similar trials

Same condition (Diabetes Mellitus, Type 2) and phase, most recent start first.